PAREXEL Ranked A Top CRO In CenterWatch Global Investigative Site Relationship Survey

Company recognised for sponsor/site relationship qualityLONDON, April 3, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organisation, today announced that it was named a top contract research organisation (CRO) in the CenterWatch 2017 Global Investigative Site Relationship Survey. The survey recognises CROs that have high-quality working relationships with investigative sites.The survey, published today in CenterWatch Monthly, polled over 1,300 global investigative sites on aspects of their relationships with CROs during the... Source: RealWire

Read More